First-in-human study confirms safety of graphene-based brain interface
Summary
Spain-based INBRAIN Neuroelectronics has completed patient recruitment for its first-in-human study evaluating a graphene-based cortical interface.
Description
Spain-based INBRAIN Neuroelectronics has completed patient recruitment for its first-in-human study evaluating a graphene-based cortical interface.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source